MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis: EGPA is categorized as an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but only 35–40 % of EGPA patients are reported to be ANCA positive, mostly are MPO-ANCA positive [2, 3].